(Q28336791)

https://api.crossref.org/works/10.1136/JNNP.38.6.592

18 September 2023

author name string

D. A. Drachman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

21 August 2022

P. Y. Paterson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

21 August 2022

R. T. Schmidt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

21 August 2022

R. F. Spehlmann

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

full work available at URL

21 August 2022

language of work or name

English

0 references

publication date

June 1975

0 references

https://europepmc.org/articles/PMC492034

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

https://europepmc.org/articles/PMC492034?pdf=render

21 August 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1097604

https://syndication.highwire.org/content/doi/10.1136/jnnp.38.6.592

21 August 2022

1 reference

Crossref

DOI

10.1136/JNNP.38.6.592

https://api.crossref.org/works/10.1136/JNNP.38.6.592

Journal of Neurology, Neurosurgery and Psychiatry

18 September 2023

published in

0 references

volume

38

0 references

issue

6

0 references

page(s)

592-7

0 references

cites work

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Chemical suppression of adaptive immunity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Multiple sclerosis: an immunologic reassessment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Immunopathological comparisons between experimental autoimmune encephalomyelitis and multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Relationship of experimental allergic encephalomyelitis to human disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Cyclophosphamide treatment of experimental allergic encephalomyelitis in Lewis rats.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Cellular Hypersensitivity to Basic Myelin (A1) Protein and Clinical Multiple Sclerosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Failure of antilymphocytic globulin therapy in chronic progressive multiple sclerosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Multiple sclerosis: brain immunoglobulin-G and albumin.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Aetiology of multiple sclerosis.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Multiple sclerosis unaffected by azathioprine in pilot study.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

SUPPRESSION OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY ANTIMETABOLITIES.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

TISSUE CULTURE STUDIES OF DEMYELINATION

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Cyclophosphamide inhibition of experimental allergic encephalomyelitis in guinea pigs

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=492034

Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis Rats

27 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1097604

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Cyclophosphamide in multiple sclerosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/1097604